{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:35:08Z","timestamp":1793054108450,"version":"4.5.0"},"update-to":[{"DOI":"10.1371\/journal.pmed.1003731","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000}}],"reference-count":142,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"VBG Group Herman Krefting Foundation on Asthma and Allergy"},{"DOI":"10.13039\/501100005761","name":"Sahlgrenska Akademin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005761","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Franklin E. Fetzer Memorial Trust","award":["R2020-16"],"award-info":[{"award-number":["R2020-16"]}]},{"name":"VBG Group Herman Krefting Foundation on Asthma and Allergy"},{"DOI":"10.13039\/501100004063","name":"Knut and Alice Wallenberg Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100017018","name":"Wallenberg Centre for Molecular and Translational Medicine","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100017018","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Background<\/jats:title><jats:p>There remains uncertainty about the impact of menopausal hormone therapy (MHT) on women\u2019s health. A systematic, comprehensive assessment of the effects on multiple outcomes is lacking. We conducted an umbrella review to comprehensively summarize evidence on the benefits and harms of MHT across diverse health outcomes.<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Methods and findings<\/jats:title><jats:p>We searched MEDLINE, EMBASE, and 10 other databases from inception to November 26, 2017, updated on December 17, 2020, to identify systematic reviews or meta-analyses of randomized controlled trials (RCTs) and observational studies investigating effects of MHT, including estrogen-alone therapy (ET) and estrogen plus progestin therapy (EPT), in perimenopausal or postmenopausal women in all countries and settings. All health outcomes in previous systematic reviews were included, including menopausal symptoms, surrogate endpoints, biomarkers, various morbidity outcomes, and mortality. Two investigators independently extracted data and assessed methodological quality of systematic reviews using the updated 16-item AMSTAR 2 instrument. Random-effects robust variance estimation was used to combine effect estimates, and 95% prediction intervals (PIs) were calculated whenever possible. We used the term MHT to encompass ET and EPT, and results are presented for MHT for each outcome, unless otherwise indicated. Sixty systematic reviews were included, involving 102 meta-analyses of RCTs and 38 of observational studies, with 102 unique outcomes. The overall quality of included systematic reviews was moderate to poor. In meta-analyses of RCTs, MHT was beneficial for vasomotor symptoms (frequency: 9 trials, 1,104 women, risk ratio [RR] 0.43, 95% CI 0.33 to 0.57,<jats:italic>p<\/jats:italic>&lt; 0.001; severity: 7 trials, 503 women, RR 0.29, 95% CI 0.17 to 0.50,<jats:italic>p<\/jats:italic>= 0.002) and all fracture (30 trials, 43,188 women, RR 0.72, 95% CI 0.62 to 0.84,<jats:italic>p<\/jats:italic>= 0.002, 95% PI 0.58 to 0.87), as well as vaginal atrophy (intravaginal ET), sexual function, vertebral and nonvertebral fracture, diabetes mellitus, cardiovascular mortality (ET), and colorectal cancer (EPT), but harmful for stroke (17 trials, 37,272 women, RR 1.17, 95% CI 1.05 to 1.29,<jats:italic>p<\/jats:italic>= 0.027) and venous thromboembolism (23 trials, 42,292 women, RR 1.60, 95% CI 0.99 to 2.58,<jats:italic>p<\/jats:italic>= 0.052, 95% PI 1.03 to 2.99), as well as cardiovascular disease incidence and recurrence, cerebrovascular disease, nonfatal stroke, deep vein thrombosis, gallbladder disease requiring surgery, and lung cancer mortality (EPT). In meta-analyses of observational studies, MHT was associated with decreased risks of cataract, glioma, and esophageal, gastric, and colorectal cancer, but increased risks of pulmonary embolism, cholelithiasis, asthma, meningioma, and thyroid, breast, and ovarian cancer. ET and EPT had opposite effects for endometrial cancer, endometrial hyperplasia, and Alzheimer disease. The major limitations include the inability to address the varying effects of MHT by type, dose, formulation, duration of use, route of administration, and age of initiation and to take into account the quality of individual studies included in the systematic reviews. The study protocol is publicly available on PROSPERO (CRD42017083412).<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Conclusions<\/jats:title><jats:p>MHT has a complex balance of benefits and harms on multiple health outcomes. Some effects differ qualitatively between ET and EPT. The quality of available evidence is only moderate to poor.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pmed.1003731","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T17:43:37Z","timestamp":1627926217000},"page":"e1003731","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":173,"title":["Menopausal hormone therapy and women\u2019s health: An umbrella review"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8785-8717","authenticated-orcid":true,"given":"Guo-Qiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6698-2607","authenticated-orcid":true,"given":"Maya B.","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8949-4312","authenticated-orcid":true,"given":"Panagiotis","family":"Anagnostis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulugbek","family":"Nurmatov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6548-358X","authenticated-orcid":true,"given":"Madar","family":"Talibov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2337-7463","authenticated-orcid":true,"given":"Catherine M.","family":"Hawrylowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2998-9185","authenticated-orcid":true,"given":"Mary Ann","family":"Lumsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Critchley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7022-3056","authenticated-orcid":true,"given":"Aziz","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Lundb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1279-1746","authenticated-orcid":true,"given":"Cecilia","family":"L\u00e4sser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5258-0906","authenticated-orcid":true,"given":"Hannu","family":"Kankaanranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5997-004X","authenticated-orcid":true,"given":"Siew Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2876-6089","authenticated-orcid":true,"given":"Bright I.","family":"Nwaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,8,2]]},"reference":[{"key":"pmed.1003731.ref001","doi-asserted-by":"crossref","DOI":"10.18356\/b564c742-en","volume-title":"World population prospects 2019","author":"United Nations Population Division","year":"2020"},{"issue":"5","key":"pmed.1003731.ref002","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/ije\/dyu094","article-title":"Socioeconomic position, lifestyle factors and age at natural menopause: a systematic review and meta-analyses of studies across six continents","volume":"43","author":"DA Schoenaker","year":"2014","journal-title":"Int J Epidemiol"},{"issue":"4","key":"pmed.1003731.ref003","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrendo.2017.180","article-title":"Symptoms of menopause\u2014global prevalence, physiology and implications","volume":"14","author":"P Monteleone","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"pmed.1003731.ref004","first-page":"976","article-title":"Menopause","volume":"27","author":"The 2020 genitourinary syndrome of menopause position statement of the North American Menopause Society","year":"2020"},{"issue":"7","key":"pmed.1003731.ref005","first-page":"728","article-title":"Menopause","volume":"24","author":"The 2017 hormone therapy position statement of the North American Menopause Society","year":"2017"},{"issue":"11","key":"pmed.1003731.ref006","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1210\/jc.2015-2236","article-title":"Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline","volume":"100","author":"CA Stuenkel","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"9980","key":"pmed.1003731.ref007","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(14)61687-1","article-title":"Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies","volume":"385","author":"V Beral","year":"2015","journal-title":"Lancet"},{"issue":"10204","key":"pmed.1003731.ref008","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(19)31709-X","article-title":"Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence","volume":"394","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"pmed.1003731.ref009","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/13697137.2015.1129166","article-title":"2016 IMS recommendations on women\u2019s midlife health and menopause hormone therapy","volume":"19","author":"RJ Baber","year":"2016","journal-title":"Climacteric"},{"issue":"22","key":"pmed.1003731.ref010","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1001\/jama.2017.18261","article-title":"Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: US Preventive Services Task Force recommendation statement","volume":"318","author":"DC Grossman","year":"2017","journal-title":"JAMA"},{"key":"pmed.1003731.ref011","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.maturitas.2016.06.001","article-title":"Revised global consensus statement on menopausal hormone therapy","volume":"91","author":"TJ de Villiers","year":"2016","journal-title":"Maturitas"},{"issue":"3","key":"pmed.1003731.ref012","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/2192568220906810","article-title":"Systematic reviews and meta-analysis in spine surgery\u2014how good are they in methodological quality? A systematic review","volume":"11","author":"M Sathish","year":"2021","journal-title":"Global Spine J"},{"issue":"11","key":"pmed.1003731.ref013","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.jpedsurg.2017.07.022","article-title":"Quality of systematic reviews and meta-analyses published in pediatric surgery","volume":"52","author":"A Salim","year":"2017","journal-title":"J Pediatr Surg"},{"issue":"3","key":"pmed.1003731.ref014","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/1468-0009.12210","article-title":"The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses","volume":"94","author":"JP Ioannidis","year":"2016","journal-title":"Milbank Q"},{"issue":"2","key":"pmed.1003731.ref015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.otohns.2008.03.020","article-title":"Evaluation of meta-analyses in the otolaryngological literature","volume":"139","author":"LR Rudmik","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"5","key":"pmed.1003731.ref016","doi-asserted-by":"crossref","first-page":"R575","DOI":"10.1186\/cc3803","article-title":"A systematic evaluation of the quality of meta-analyses in the critical care literature","volume":"9","author":"A Delaney","year":"2005","journal-title":"Crit Care"},{"issue":"7234","key":"pmed.1003731.ref017","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/bmj.320.7234.537","article-title":"Systematic reviews and meta-analyses on treatment of asthma: critical evaluation","volume":"320","author":"AR Jadad","year":"2000","journal-title":"BMJ"},{"issue":"1","key":"pmed.1003731.ref018","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2106\/JBJS.I.00251","article-title":"Twenty years of meta-analyses in orthopaedic surgery: has quality kept up with quantity?","volume":"92","author":"BG Dijkman","year":"2010","journal-title":"J Bone Joint Surg Am"},{"issue":"3","key":"pmed.1003731.ref019","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1214\/19-STS728","article-title":"Outcome-wide longitudinal designs for causal inference: a new template for empirical studies","volume":"35","author":"TJ VanderWeele","year":"2020","journal-title":"Stat Sci"},{"issue":"8","key":"pmed.1003731.ref020","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1503\/cmaj.081086","article-title":"Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses","volume":"181","author":"JP Ioannidis","year":"2009","journal-title":"CMAJ"},{"issue":"3","key":"pmed.1003731.ref021","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/XEB.0000000000000055","article-title":"Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach","volume":"13","author":"E Aromataris","year":"2015","journal-title":"Int J Evid Based Healthc"},{"issue":"3","key":"pmed.1003731.ref022","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/ebmental-2018-300014","article-title":"Ten simple rules for conducting umbrella reviews","volume":"21","author":"P Fusar-Poli","year":"2018","journal-title":"Evid Based Ment Health"},{"issue":"3","key":"pmed.1003731.ref023","doi-asserted-by":"crossref","first-page":"e1003583","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"18","author":"MJ Page","year":"2021","journal-title":"PLoS Med"},{"key":"pmed.1003731.ref024","author":"World Health Organization","year":"2020"},{"issue":"16","key":"pmed.1003731.ref025","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/eurheartj\/ehn299","article-title":"Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis","volume":"29","author":"GM Sare","year":"2008","journal-title":"Eur Heart J"},{"issue":"5","key":"pmed.1003731.ref026","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1463-1326.2005.00545.x","article-title":"Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women","volume":"8","author":"SR Salpeter","year":"2006","journal-title":"Diabetes Obes Metab"},{"issue":"17","key":"pmed.1003731.ref027","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.ejca.2011.04.023","article-title":"Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis","volume":"47","author":"S Gandini","year":"2011","journal-title":"Eur J Cancer"},{"issue":"5","key":"pmed.1003731.ref028","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/1010539513488795","article-title":"Risk factors of breast cancer: a systematic review and meta-analysis","volume":"25","author":"T Anothaisintawee","year":"2013","journal-title":"Asia Pac J Public Health"},{"issue":"1","key":"pmed.1003731.ref029","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12874-017-0431-4","article-title":"Frequency of data extraction errors and methods to increase data extraction quality: a methodological review","volume":"17","author":"T Mathes","year":"2017","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"pmed.1003731.ref030","first-page":"CD004143","article-title":"Long-term hormone therapy for perimenopausal and postmenopausal women.","volume":"1","author":"J Marjoribanks","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"pmed.1003731.ref031","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/jama.2020.9482","article-title":"Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the Women\u2019s Health Initiative randomized clinical trials","volume":"324","author":"RT Chlebowski","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"pmed.1003731.ref032","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cllc.2015.09.004","article-title":"Estrogen plus progestin and lung cancer: follow-up of the Women\u2019s Health Initiative randomized trial","volume":"17","author":"RT Chlebowski","year":"2016","journal-title":"Clin Lung Cancer"},{"issue":"10","key":"pmed.1003731.ref033","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jama.2017.11217","article-title":"Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women\u2019s Health Initiative randomized trials","volume":"318","author":"JE Manson","year":"2017","journal-title":"JAMA"},{"issue":"13","key":"pmed.1003731.ref034","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"The Women\u2019s Health Initiative hormone therapy trials: update and overview of health outcomes during the intervention and post-stopping phases","volume":"310","author":"JE Manson","year":"2013","journal-title":"JAMA"},{"key":"pmed.1003731.ref035","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"BJ Shea","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"pmed.1003731.ref036","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jrsm.5","article-title":"Robust variance estimation in meta-regression with dependent effect size estimates","volume":"1","author":"LV Hedges","year":"2010","journal-title":"Res Synth Methods"},{"issue":"11","key":"pmed.1003731.ref037","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"JP Higgins","year":"2002","journal-title":"Stat Med"},{"key":"pmed.1003731.ref038","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2288-8-79","article-title":"Undue reliance on I2 in assessing heterogeneity may mislead","volume":"8","author":"G R\u00fccker","year":"2008","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"pmed.1003731.ref039","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","article-title":"A re-evaluation of random-effects meta-analysis","volume":"172","author":"JP Higgins","year":"2009","journal-title":"J R Stat Soc Ser A Stat Soc"},{"issue":"2","key":"pmed.1003731.ref040","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/jrsm.1345","article-title":"A simple method to estimate prediction intervals and predictive distributions: summarizing meta-analyses beyond means and confidence intervals","volume":"10","author":"CC Wang","year":"2019","journal-title":"Res Synth Methods"},{"issue":"8","key":"pmed.1003731.ref041","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/sim.8057","article-title":"New metrics for meta-analyses of heterogeneous effects","volume":"38","author":"MB Mathur","year":"2019","journal-title":"Stat Med"},{"issue":"3","key":"pmed.1003731.ref042","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/EDE.0000000000001180","article-title":"Robust metrics and sensitivity analyses for meta-analyses of heterogeneous effects","volume":"31","author":"MB Mathur","year":"2020","journal-title":"Epidemiology"},{"issue":"2","key":"pmed.1003731.ref043","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jphys.2020.02.011","article-title":"Research note: in a meta-analysis, the I2 index does not tell us how much the effect size varies across studies","volume":"66","author":"M. Borenstein","year":"2020","journal-title":"J Physiother"},{"issue":"11","key":"pmed.1003731.ref044","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0895-4356(00)00242-0","article-title":"Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature","volume":"53","author":"JA Sterne","year":"2000","journal-title":"J Clin Epidemiol"},{"issue":"7109","key":"pmed.1003731.ref045","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"M Egger","year":"1997","journal-title":"BMJ"},{"issue":"3","key":"pmed.1003731.ref046","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF02294384","article-title":"A general linear model for estimating effect size in the presence of publication bias","volume":"60","author":"JL Vevea","year":"1995","journal-title":"Psychometrika"},{"issue":"5","key":"pmed.1003731.ref047","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/rssc.12440","article-title":"Sensitivity analysis for publication bias in meta-analyses","volume":"69","author":"MB Mathur","year":"2020","journal-title":"J R Stat Soc Ser C Appl Stat"},{"issue":"4","key":"pmed.1003731.ref048","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"TJ VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"issue":"5","key":"pmed.1003731.ref049","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/EDE.0000000000000864","article-title":"Website and R package for computing E-values","volume":"29","author":"MB Mathur","year":"2018","journal-title":"Epidemiology"},{"issue":"529","key":"pmed.1003731.ref050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/01621459.2018.1529598","article-title":"Sensitivity analysis for unmeasured confounding in meta-analyses","volume":"115","author":"MB Mathur","year":"2020","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"pmed.1003731.ref051","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/sim.4780030421","article-title":"Why do we need some large, simple randomized trials?","volume":"3","author":"S Yusuf","year":"1984","journal-title":"Stat Med."},{"issue":"1","key":"pmed.1003731.ref052","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/jama.1991.03470010097038","article-title":"Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials","volume":"266","author":"S Yusuf","year":"1991","journal-title":"JAMA"},{"issue":"1","key":"pmed.1003731.ref053","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1037\/0033-2909.117.1.167","article-title":"Meta-analysis of screening and diagnostic tests","volume":"117","author":"V Hasselblad","year":"1995","journal-title":"Psychol Bull"},{"issue":"3","key":"pmed.1003731.ref054","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/biom.13197","article-title":"Optimal approximate conversions of odds ratios and hazard ratios to risk ratios","volume":"76","author":"TJ VanderWeele","year":"2020","journal-title":"Biometrics"},{"issue":"2","key":"pmed.1003731.ref055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3102\/10769986006002107","article-title":"Distribution theory for Glass\u2019s estimator of effect size and related estimators.","volume":"6","author":"LV Hedges","year":"1981","journal-title":"J Educ Behav Stat"},{"key":"pmed.1003731.ref056","volume-title":"R: a language and environment for statistical computing.","author":"R Core Team","year":"2020"},{"issue":"3","key":"pmed.1003731.ref057","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3109\/13697137.2016.1164136","article-title":"Effects of hormone replacement therapy on immunological factors in the postmenopausal period","volume":"19","author":"F Abdi","year":"2016","journal-title":"Climacteric"},{"key":"pmed.1003731.ref058","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.maturitas.2017.02.009","article-title":"The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: a systematic review and meta-analysis","volume":"99","author":"P Anagnostis","year":"2017","journal-title":"Maturitas"},{"issue":"11","key":"pmed.1003731.ref059","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1210\/jc.2015-2238","article-title":"Menopausal hormone therapy and mortality: a systematic review and meta-analysis","volume":"100","author":"K Benkhadra","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"pmed.1003731.ref060","first-page":"CD002229","article-title":"Hormone therapy for preventing cardiovascular disease in post-menopausal women","volume":"2015","author":"HM Boardman","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"pmed.1003731.ref061","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1210\/jc.2014-3301","article-title":"Effects of low-dose versus placebo or conventional-dose postmenopausal hormone therapy on variables related to cardiovascular risk: a systematic review and meta-analyses of randomized clinical trials","volume":"100","author":"G Casanova","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"pmed.1003731.ref062","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s12020-016-1072-9","article-title":"Efficacy of menopausal hormone therapy on sleep quality: systematic review and meta-analysis","volume":"55","author":"D Cintron","year":"2017","journal-title":"Endocrine"},{"issue":"10","key":"pmed.1003731.ref063","first-page":"CD001405","article-title":"Oestrogen therapy for urinary incontinence in post-menopausal women","volume":"10","author":"JD Cody","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"pmed.1003731.ref064","first-page":"CD000402","article-title":"Hormone therapy in postmenopausal women and risk of endometrial hyperplasia","volume":"2012","author":"S Furness","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"pmed.1003731.ref065","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/gerona\/glp082","article-title":"Hormone therapy and skeletal muscle strength: a meta-analysis","volume":"64","author":"SM Greising","year":"2009","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"pmed.1003731.ref066","first-page":"CD003799","article-title":"Hormone replacement therapy to maintain cognitive function in women with dementia","volume":"2009","author":"E Hogervorst","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"pmed.1003731.ref067","first-page":"CD001018","article-title":"Oestrogen and progestogen hormone replacement therapy for peri\u2010menopausal and post\u2010menopausal women: weight and body fat distribution","volume":"1999","author":"EJ Kongnyuy","year":"1999","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"pmed.1003731.ref068","first-page":"CD001500","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women","volume":"2016","author":"A Lethaby","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"pmed.1003731.ref069","first-page":"CD003122","article-title":"Hormone replacement therapy for cognitive function in postmenopausal women","volume":"2008","author":"A Lethaby","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"pmed.1003731.ref070","first-page":"CD000402","article-title":"The association of oestrogen, oestrogen\u2010progestogen and placebo with endometrial hyperplasia and irregular bleeding in the menopause","volume":"1999","author":"AE Lethaby","year":"1999","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"pmed.1003731.ref071","first-page":"CD002978","article-title":"Oral oestrogen and combined oestrogen\/progestogen therapy versus placebo for hot flushes","volume":"2004","author":"AH Maclennan","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"pmed.1003731.ref072","first-page":"CD009672","article-title":"Hormone therapy for sexual function in perimenopausal and postmenopausal women","volume":"2013","author":"CO Nastri","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"pmed.1003731.ref073","first-page":"CD005131","article-title":"Oestrogens for preventing recurrent urinary tract infection in postmenopausal women","volume":"2008","author":"C Perrotta","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"pmed.1003731.ref074","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1097\/GME.0000000000000657","article-title":"Hormone therapy and clinical and surrogate cardiovascular endpoints in women with chronic kidney disease: a systematic review and meta-analysis","volume":"23","author":"S Ramesh","year":"2016","journal-title":"Menopause"},{"issue":"12","key":"pmed.1003731.ref075","first-page":"CD009146","article-title":"Hormone replacement for osteoporosis in women with primary biliary cirrhosis","volume":"2011","author":"JS Rudic","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"pmed.1003731.ref076","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1525-1497.2004.30281.x","article-title":"Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis","volume":"19","author":"SR Salpeter","year":"2004","journal-title":"J Gen Intern Med"},{"key":"pmed.1003731.ref077","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2474-2-7","article-title":"Hormone replacement therapy and prevention of vertebral fractures: a meta-analysis of randomised trials","volume":"2","author":"DJ Torgerson","year":"2001","journal-title":"BMC Musculoskelet Disord"},{"issue":"22","key":"pmed.1003731.ref078","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1001\/jama.285.22.2891","article-title":"Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials","volume":"285","author":"DJ Torgerson","year":"2001","journal-title":"JAMA"},{"issue":"4","key":"pmed.1003731.ref079","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1210\/er.2001-5002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women","volume":"23","author":"G Wells","year":"2002","journal-title":"Endocr Rev"},{"issue":"1","key":"pmed.1003731.ref080","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/jwh.2015.5628","article-title":"Bioidentical estrogen for menopausal depressive symptoms: a systematic review and meta-analysis","volume":"26","author":"JM Whedon","year":"2017","journal-title":"J Womens Health"},{"issue":"5","key":"pmed.1003731.ref081","doi-asserted-by":"crossref","first-page":"e62329","DOI":"10.1371\/journal.pone.0062329","article-title":"Effect of hormone replacement therapy on cardiovascular outcomes: a meta-analysis of randomized controlled trials","volume":"8","author":"D Yang","year":"2013","journal-title":"PLoS ONE"},{"issue":"4","key":"pmed.1003731.ref082","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/GME.0000000000000519","article-title":"Effect of hormone therapy on the risk of bone fractures: a systematic review and meta-analysis of randomized controlled trials","volume":"23","author":"L Zhu","year":"2016","journal-title":"Menopause"},{"issue":"1","key":"pmed.1003731.ref083","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1158\/1055-9965.EPI-11-0834","article-title":"Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis","volume":"21","author":"MC Camargo","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7655","key":"pmed.1003731.ref084","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.39555.441944.BE","article-title":"Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis","volume":"336","author":"M Canonico","year":"2008","journal-title":"BMJ"},{"key":"pmed.1003731.ref085","first-page":"103515","article-title":"Reproductive factors but not hormonal factors associated with thyroid cancer risk: a systematic review and meta-analysis","volume":"2015","author":"Y Cao","year":"2015","journal-title":"Biomed Res Int"},{"issue":"2","key":"pmed.1003731.ref086","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/rheumatology\/ken390","article-title":"Limited evidence for a protective effect of unopposed oestrogen therapy for osteoarthritis of the hip: a systematic review","volume":"48","author":"BM de Klerk","year":"2009","journal-title":"Rheumatology."},{"issue":"2","key":"pmed.1003731.ref087","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0029-7844(94)00383-O","article-title":"Hormone replacement therapy and endometrial cancer risk: a meta-analysis","volume":"85","author":"D Grady","year":"1995","journal-title":"Obstet Gynecol"},{"issue":"10","key":"pmed.1003731.ref088","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/ijc.26236","article-title":"Menopausal hormone therapy and risk of gastrointestinal cancer: nested case-control study within a prospective cohort, and meta-analysis","volume":"130","author":"J Green","year":"2012","journal-title":"Int J Cancer"},{"issue":"5","key":"pmed.1003731.ref089","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/humupd\/dmm012","article-title":"Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis","volume":"13","author":"CM Greiser","year":"2007","journal-title":"Hum Reprod Update"},{"issue":"4","key":"pmed.1003731.ref090","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/0003-4819-137-4-200208200-00012","article-title":"Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease","volume":"137","author":"LL Humphrey","year":"2002","journal-title":"Ann Intern Med"},{"issue":"10","key":"pmed.1003731.ref091","doi-asserted-by":"crossref","first-page":"e78647","DOI":"10.1371\/journal.pone.0078647","article-title":"The effects of postmenopausal hormone use on cataract: a meta-analysis","volume":"8","author":"K Lai","year":"2013","journal-title":"PLoS ONE"},{"issue":"11","key":"pmed.1003731.ref092","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/jama.285.11.1489","article-title":"Hormone replacement therapy and cognition: systematic review and meta-analysis","volume":"285","author":"ES LeBlanc","year":"2001","journal-title":"JAMA"},{"key":"pmed.1003731.ref093","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.steroids.2016.12.005","article-title":"Hormone therapy and lung cancer mortality in women: systematic review and meta-analysis","volume":"118","author":"W Li","year":"2017","journal-title":"Steroids"},{"issue":"4","key":"pmed.1003731.ref094","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3892\/or.2017.5867","article-title":"Age at menopause and hormone replacement therapy as risk factors for head and neck and oesophageal cancer (review)","volume":"38","author":"CE McCarthy","year":"2017","journal-title":"Oncol Rep"},{"issue":"4","key":"pmed.1003731.ref095","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jaci.2017.11.034","article-title":"Endogenous and exogenous sex steroid hormones in asthma and allergy in females: a systematic review and meta-analysis","volume":"141","author":"N McCleary","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"pmed.1003731.ref096","doi-asserted-by":"crossref","first-page":"e83261","DOI":"10.1371\/journal.pone.0083261","article-title":"Reproductive and exogenous hormone factors in relation to risk of meningioma in women: a meta-analysis","volume":"8","author":"ZY Qi","year":"2013","journal-title":"PLoS ONE"},{"issue":"7","key":"pmed.1003731.ref097","doi-asserted-by":"crossref","first-page":"e68695","DOI":"10.1371\/journal.pone.0068695","article-title":"Exogenous and endogenous hormones in relation to glioma in women: a meta-analysis of 11 case-control studies","volume":"8","author":"ZY Qi","year":"2013","journal-title":"PLoS ONE"},{"issue":"8","key":"pmed.1003731.ref098","doi-asserted-by":"crossref","first-page":"e104303","DOI":"10.1371\/journal.pone.0104303","article-title":"Safety of hormonal replacement therapy and oral contraceptives in systemic lupus erythematosus: a systematic review and meta-analysis","volume":"9","author":"A Rojas-Villarraga","year":"2014","journal-title":"PLoS ONE"},{"issue":"11","key":"pmed.1003731.ref099","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.amjmed.2009.05.021","article-title":"Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women","volume":"122","author":"SR Salpeter","year":"2009","journal-title":"Am J Med"},{"issue":"9","key":"pmed.1003731.ref100","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ejca.2014.03.006","article-title":"Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors: a meta-analysis","volume":"50","author":"SH Shim","year":"2014","journal-title":"Eur J Cancer"},{"issue":"7","key":"pmed.1003731.ref101","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1097\/MD.0000000000000177","article-title":"Relationship between female hormonal and menstrual factors and pancreatic cancer: a meta-analysis of observational studies","volume":"94","author":"B Tang","year":"2015","journal-title":"Medicine"},{"key":"pmed.1003731.ref102","first-page":"59","article-title":"Hormone replacement therapy and Parkinson\u2019s disease risk in women: a meta-analysis of 14 observational studies","volume":"11","author":"P Wang","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"14","key":"pmed.1003731.ref103","doi-asserted-by":"crossref","first-page":"e6556","DOI":"10.1097\/MD.0000000000006556","article-title":"Is the oral contraceptive or hormone replacement therapy a risk factor for cholelithiasis: a systematic review and meta-analysis","volume":"96","author":"S Wang","year":"2017","journal-title":"Medicine"},{"issue":"8","key":"pmed.1003731.ref104","doi-asserted-by":"crossref","first-page":"e71236","DOI":"10.1371\/journal.pone.0071236","article-title":"Hormone replacement therapy in females can decrease the risk of lung cancer: a meta-analysis","volume":"8","author":"Y Yao","year":"2013","journal-title":"PLoS ONE"},{"issue":"5","key":"pmed.1003731.ref105","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s12282-017-0789-5","article-title":"Hormone replacement therapy and breast cancer survival: a systematic review and meta-analysis of observational studies","volume":"24","author":"X Yu","year":"2017","journal-title":"Breast Cancer"},{"issue":"1","key":"pmed.1003731.ref106","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/humupd\/dmw037","article-title":"Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies","volume":"23","author":"GC Zhong","year":"2016","journal-title":"Hum Reprod Update"},{"issue":"1","key":"pmed.1003731.ref107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CEJ.0000000000000234","article-title":"Reproductive factors are associated with oesophageal cancer risk: results from a meta-analysis of observational studies","volume":"26","author":"Y Zhu","year":"2017","journal-title":"Eur J Cancer Prev"},{"issue":"4","key":"pmed.1003731.ref108","doi-asserted-by":"crossref","first-page":"R535","DOI":"10.1186\/bcr1035","article-title":"Menopausal hormone therapy after breast cancer: a meta-analysis and critical appraisal of the evidence","volume":"7","author":"NF Col","year":"2005","journal-title":"Breast Cancer Res"},{"issue":"2","key":"pmed.1003731.ref109","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ygyno.2015.07.109","article-title":"Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis","volume":"139","author":"D Li","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"1","key":"pmed.1003731.ref110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/epirev\/mxt008","article-title":"Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer\u2019s disease","volume":"36","author":"J O\u2019Brien","year":"2014","journal-title":"Epidemiol Rev"},{"issue":"7","key":"pmed.1003731.ref111","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.kjms.2014.03.002","article-title":"Combined estrogen replacement therapy on metabolic control in postmenopausal women with diabetes mellitus","volume":"30","author":"Y Xu","year":"2014","journal-title":"Kaohsiung J Med Sci"},{"issue":"3","key":"pmed.1003731.ref112","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jama.2018.19684","article-title":"Random-effects meta-analysis: summarizing evidence with caveats","volume":"321","author":"S Serghiou","year":"2019","journal-title":"JAMA"},{"key":"pmed.1003731.ref113","doi-asserted-by":"crossref","first-page":"d549","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"RD Riley","year":"2011","journal-title":"BMJ"},{"issue":"12","key":"pmed.1003731.ref114","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1002\/ijc.33174","article-title":"Menopausal hormone therapy use and long-term all-cause and cause-specific mortality in the Long Island Breast Cancer Study Project","volume":"147","author":"T Wang","year":"2020","journal-title":"Int J Cancer"},{"issue":"3","key":"pmed.1003731.ref115","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.ygyno.2020.06.481","article-title":"Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival","volume":"158","author":"KK Brieger","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"10204","key":"pmed.1003731.ref116","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(19)32033-1","article-title":"Menopausal hormone therapy and 20-year breast cancer mortality","volume":"394","author":"V Beral","year":"2019","journal-title":"Lancet"},{"issue":"8","key":"pmed.1003731.ref117","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/ijc.28990","article-title":"Cancer incidence, survival and mortality: explaining the concepts","volume":"135","author":"L Ellis","year":"2014","journal-title":"Int J Cancer"},{"issue":"9407","key":"pmed.1003731.ref118","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","article-title":"HABITS (hormonal replacement therapy after breast cancer\u2014is it safe?), a randomised comparison: trial stopped","volume":"363","author":"L Holmberg","year":"2004","journal-title":"Lancet"},{"issue":"7","key":"pmed.1003731.ref119","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn058","article-title":"Increased risk of recurrence after hormone replacement therapy in breast cancer survivors","volume":"100","author":"L Holmberg","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"7435","key":"pmed.1003731.ref120","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1136\/bmj.328.7435.305-a","article-title":"Another HRT trial is stopped early","volume":"328","author":"O. Dyer","year":"2004","journal-title":"BMJ"},{"issue":"1","key":"pmed.1003731.ref121","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejca.2012.07.003","article-title":"Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial","volume":"49","author":"M Fahl\u00e9n","year":"2013","journal-title":"Eur J Cancer"},{"issue":"6","key":"pmed.1003731.ref122","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/GME.0000000000001121","article-title":"Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from the North American Menopause Society and the International Society for the Study of Women\u2019s Sexual Health","volume":"25","author":"SS Faubion","year":"2018","journal-title":"Menopause"},{"issue":"3","key":"pmed.1003731.ref123","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/13697137.2012.656401","article-title":"The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspective","volume":"15","author":"HN Hodis","year":"2012","journal-title":"Climacteric"},{"issue":"3","key":"pmed.1003731.ref124","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/gme.0b013e3182843aad","article-title":"Timing hypothesis for postmenopausal hormone therapy: its origin, current status, and future","volume":"20","author":"TB Clarkson","year":"2013","journal-title":"Menopause"},{"issue":"4","key":"pmed.1003731.ref125","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nrendo.2016.164","article-title":"Hormone-replacement therapy: current thinking","volume":"13","author":"RA Lobo","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"pmed.1003731.ref126","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/GME.0000000000001553","article-title":"The Women\u2019s Health Initiative trials of menopausal hormone therapy: lessons learned","volume":"27","author":"JE Manson","year":"2020","journal-title":"Menopause"},{"issue":"5","key":"pmed.1003731.ref127","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/13697137.2017.1362156","article-title":"Menopausal hormone therapy for primary prevention: why the USPSTF is wrong","volume":"20","author":"RD Langer","year":"2017","journal-title":"Climacteric."},{"issue":"13","key":"pmed.1003731.ref128","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMe1602846","article-title":"Postmenopausal hormone therapy and atherosclerosis\u2014time is of the essence","volume":"374","author":"JF Keaney","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"pmed.1003731.ref129","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1525-1497.2006.00389.x","article-title":"Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis","volume":"21","author":"SR Salpeter","year":"2006","journal-title":"J Gen Intern Med"},{"issue":"1","key":"pmed.1003731.ref130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-116-1-78","article-title":"A consumer\u2019s guide to subgroup analyses","volume":"116","author":"AD Oxman","year":"1992","journal-title":"Ann Intern Med"},{"key":"pmed.1003731.ref131","doi-asserted-by":"crossref","first-page":"c117","DOI":"10.1136\/bmj.c117","article-title":"Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses","volume":"340","author":"X Sun","year":"2010","journal-title":"BMJ"},{"issue":"22","key":"pmed.1003731.ref132","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1001\/jama.2017.16952","article-title":"Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: evidence report and systematic review for the US Preventive Services Task Force","volume":"318","author":"G Gartlehner","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"pmed.1003731.ref133","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cegh.2018.05.005","article-title":"Interpretation of subgroup analyses in systematic reviews: a tutorial","volume":"7","author":"M Richardson","year":"2019","journal-title":"Clin Epidemiol Glob Health"},{"issue":"13","key":"pmed.1003731.ref134","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1505241","article-title":"Vascular effects of early versus late postmenopausal treatment with estradiol","volume":"374","author":"HN Hodis","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"pmed.1003731.ref135","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/M14-0353","article-title":"Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial","volume":"161","author":"SM Harman","year":"2014","journal-title":"Ann Intern Med"},{"issue":"12","key":"pmed.1003731.ref136","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"JC Cohen","year":"2006","journal-title":"N Engl J Med"},{"issue":"9","key":"pmed.1003731.ref137","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/eurheartj\/eht571","article-title":"Mendelian randomization of blood lipids for coronary heart disease","volume":"36","author":"MV Holmes","year":"2015","journal-title":"Eur Heart J"},{"issue":"9726","key":"pmed.1003731.ref138","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0140-6736(10)60545-4","article-title":"Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies","volume":"375","author":"N Sarwar","year":"2010","journal-title":"Lancet"},{"issue":"22","key":"pmed.1003731.ref139","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.","volume":"301","author":"PR Kamstrup","year":"2009","journal-title":"JAMA"},{"issue":"6","key":"pmed.1003731.ref140","doi-asserted-by":"crossref","first-page":"e004918","DOI":"10.1161\/JAHA.116.004918","article-title":"Causal effect of plasminogen activator inhibitor type 1 on coronary heart disease","volume":"6","author":"C Song","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"pmed.1003731.ref141","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jama.293.8.935","article-title":"Effects of estrogen with and without progestin on urinary incontinence","volume":"293","author":"SL Hendrix","year":"2005","journal-title":"JAMA"},{"issue":"2","key":"pmed.1003731.ref142","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"M Borenstein","year":"2010","journal-title":"Res Synth Methods"}],"updated-by":[{"DOI":"10.1371\/journal.pmed.1003731","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000}}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003731","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T20:08:31Z","timestamp":1699301311000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003731"}},"subtitle":[],"editor":[{"given":"Jenny E.","family":"Myers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,8,2]]},"references-count":142,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1003731","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pmed.1003731","asserted-by":"object"}]},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,2]]}}}